| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/28/2004 | EP1440072A2 Purine analogs having hsp90-inhibiting activity |
| 07/28/2004 | EP1440071A1 Imidazopyridine compounds as 5-ht 4? receptor modulators |
| 07/28/2004 | EP1440070A1 4-(5-membered)-heteroaryl acyl pyrrolidine derivatives as hcv inhibitors |
| 07/28/2004 | EP1440069A1 4-(6-membered)-heteroaryl acyl pyrrolidine derivatives as hcv inhibitors |
| 07/28/2004 | EP1440068A1 Acyl dihydro pyrrole derivatives as hcv inhibitors |
| 07/28/2004 | EP1440066A1 Pyrazolyl-substituted heterocycles and their use as phytosanitary products |
| 07/28/2004 | EP1440062A1 An efficient synthesis of 5-heteroatom-containing-pyrazoles |
| 07/28/2004 | EP1440060A1 4(piperidin-4-yliden-(3-carbamoylphenyl)methyl] benzamide derivatives and their use for the treatment of pain, spinal injuries or gastrointestinal disorders |
| 07/28/2004 | EP1440059A1 3-azabicyclo(3.1.0)hexane derivatives as opioid receptor antagonists |
| 07/28/2004 | EP1440057A1 Allenic aryl sulfonamide hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 07/28/2004 | EP1440052A1 Benzamide derivatives as antagonists of orexin receptors |
| 07/28/2004 | EP1439885A1 Simplified sarcodictyn derivatives as anti-tumor agents |
| 07/28/2004 | EP1439878A2 Method and apparatus for dispensing inhalator medicament |
| 07/28/2004 | EP1439869A1 Stents |
| 07/28/2004 | EP1439864A2 Methods for the treatment and diagnosis of tumorigenic and angiogenic disorders using 32616 |
| 07/28/2004 | EP1439863A2 Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism |
| 07/28/2004 | EP1439862A2 Methods and compositions for the treatment and diagnosis of pain disorders using 9805 |
| 07/28/2004 | EP1439858A1 Use of granular materials based on pyrogenically produced silicon dioxide in pharmaceutical compositions |
| 07/28/2004 | EP1439855A1 Composition and method for minimizing or avoiding adverse effects of vesicants |
| 07/28/2004 | EP1439853A2 Means for inhibition of lentiviruses |
| 07/28/2004 | EP1439849A2 Use of calmodulin kinase ii inhibitors to treat myocardial dysfunction in structural heart disease |
| 07/28/2004 | EP1439847A1 Method and composition for repairing and promoting regeneration of mucosal tissue in the gastrointestinal tract |
| 07/28/2004 | EP1439844A1 Pharmaceutical preparation comprising a growth factor and/or a cytokine and an antiseptic biguanide |
| 07/28/2004 | EP1439843A2 Tetracycline derivatives and methods of use thereof |
| 07/28/2004 | EP1439842A1 Oxidant scavengers for treatment of diabetes or use in transplantation or induction of immune tolerance |
| 07/28/2004 | EP1439841A2 Androgen receptor modulators and methods of use thereof |
| 07/28/2004 | EP1439840A1 Monobactam antibacterial compounds and methods of use thereof |
| 07/28/2004 | EP1439839A1 A combination comprising combretastatin and anticancer agents |
| 07/28/2004 | EP1439838A1 Macrolides containing pharmaceutical compositions |
| 07/28/2004 | EP1439837A1 Pyrazolidinone compounds as ligands of the prostaglandin ep2 and/or ep4 receptors |
| 07/28/2004 | EP1439836A1 Nicotinic acetylcholine receptor agonists in the treatment of restless legs syndrome |
| 07/28/2004 | EP1439835A2 Medical compositions for intravesical treatment of bladder cancer |
| 07/28/2004 | EP1439834A1 Oxindole hydrazide modulators of protein tyrosine phosphatases (ptps) |
| 07/28/2004 | EP1439833A1 Combination of liponic acid and glutamine in food and pharmaceutical products |
| 07/28/2004 | EP1439832A1 Method of treating acne vulgaris using avermectin compound |
| 07/28/2004 | EP1439831A1 Pharmaco-dietary preparation having a nutrition-supplementing and nutrition-enhancing effect |
| 07/28/2004 | EP1439830A1 Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid |
| 07/28/2004 | EP1439829A1 Pharmaceutical containing 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol and providing delayed release of the active ingredient |
| 07/28/2004 | EP1439828A2 Veterinaire florfenicol formulation that is syringeable under cold weather conditions |
| 07/28/2004 | EP1439827A2 Inhalation of vapour of therapeutical substances |
| 07/28/2004 | EP1439826A1 Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract |
| 07/28/2004 | EP1439825A1 Methods of treatment using a gastric retained gabapentin dosage |
| 07/28/2004 | EP1439824A2 Three-dimensional suspension printing of dosage forms |
| 07/28/2004 | EP1439823A1 Pharmaceutical formulation comprising (r)-bicalutamide |
| 07/28/2004 | EP1439820A2 Methods and dosage forms for improving the bioavailability of therapeutic agents |
| 07/28/2004 | EP1439819A1 Formulation of an erodible, gastic retentive oral dosage form using in vitro disintegration test data |
| 07/28/2004 | EP1439818A1 Chewable tablet containing lysine |
| 07/28/2004 | EP1439758A1 Non-lauric, non-trans, non-temper fat compositions |
| 07/28/2004 | EP1401473A4 Transporters comprising spaced arginine moieties |
| 07/28/2004 | EP1389197A4 Two-step conversion of protected taxane ester to paclitaxel |
| 07/28/2004 | EP1372659B1 Substances for use in therapy of diseases that are caused by highly proliferative cells |
| 07/28/2004 | EP1322593B1 O-substituted 6-methyl-tramadol derivatives |
| 07/28/2004 | EP1322592B1 Substituted 1-aminobutan-3-ol derivatives |
| 07/28/2004 | EP1317264B1 Combination of lipoic acids and conjugated acids for treating diabetic disorders |
| 07/28/2004 | EP1311660A4 METHOD OF SCREENING FOR INHIBITORS OF HUMAN FATTY ACID-CoA LIGASE 4 |
| 07/28/2004 | EP1284749B1 Use of hyaluronidase for preventing and treating cardio vascular diseases |
| 07/28/2004 | EP1267858B1 Diphenyl ketoaldehyde derivatives with anti-hiv activity |
| 07/28/2004 | EP1242062B1 Anhydrous gel comprising nsaid for topical administration to the oral cavity |
| 07/28/2004 | EP1225875B1 Apparatus and process for preparing crystalline particles |
| 07/28/2004 | EP1220667B1 Beta-agonists for treating endometriosis or infertility, or improving fertility |
| 07/28/2004 | EP1206428B1 Use of hydroxyethers in cosmetic and pharmaceutical preparations |
| 07/28/2004 | EP1180094B1 Fused polycyclic amino acids as pharmaceutical agents |
| 07/28/2004 | EP1176958B1 Novel catechols as antimicrobial agents |
| 07/28/2004 | EP1171003B1 Complete feed for fish larvae and method for preparing same |
| 07/28/2004 | EP1140862A4 THROMBIN OR FACTOR Xa INHIBITORS |
| 07/28/2004 | EP1137632B1 Thiourea inhibitors of herpes viruses |
| 07/28/2004 | EP1090668B1 Chelate-forming filter, process for producing the same |
| 07/28/2004 | EP1077692B1 Amino acid stabilized gabapentin and pregabalin preparations and process for preparing the same |
| 07/28/2004 | EP1073430B1 Use of nmda antagonists and/or sodium channel antagonists for the treatment of inflammatory disorders |
| 07/28/2004 | EP1063968B1 Improved compositions for inhalation |
| 07/28/2004 | EP1061802B1 Topical carbamazepine formulations and methods of use |
| 07/28/2004 | EP1058698B1 Preparation for prevention and healing of inflammation affections |
| 07/28/2004 | EP1058546A4 Composition and method for treating macular disorders |
| 07/28/2004 | EP1052996B1 Medicine for treating apoptosis dysfunction containing oligosaccharides |
| 07/28/2004 | EP1051383B1 Hydroxylation activated prodrugs |
| 07/28/2004 | EP1030673B1 Use of ketolides for preventing arterial thrombotic complications related to atherosclerosis |
| 07/28/2004 | EP1009412B1 Use of inosine for the manufacture of a medicament for stimulating axonal outgrowth of central nervous system neurons |
| 07/28/2004 | EP1001761B1 Use of cholinesterase inhibitors for treating attention deficit disorders |
| 07/28/2004 | EP0988040B1 Use of glucosamine and glucosamine derivatives for quick alleviation of itching or localized pain |
| 07/28/2004 | EP0983286B1 Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors |
| 07/28/2004 | EP0946174B1 Treatment of urinary incontinence and compositions for use therein |
| 07/28/2004 | EP0931065B1 use of NITRIC ESTER DERIVATIVES IN the treatment of URINARY INCONTINENCE |
| 07/28/2004 | EP0927183B1 Spirocyclic metalloprotease inhibitors |
| 07/28/2004 | EP0861073B1 Stabilized thyroid hormone preparations and methods of making same |
| 07/28/2004 | EP0831821B1 Optically pure (-) norcisapride for treating digestive tract disorders |
| 07/28/2004 | EP0823897B1 Nicotinic acid esters and pharmaceutical compositions containing them |
| 07/28/2004 | EP0823895B1 Fatty acid esters as bioactive compounds |
| 07/28/2004 | EP0805816B1 Compounds with growth hormone releasing properties |
| 07/28/2004 | EP0735885B1 Ointments comprising mometasone furoate and salicylic acid for the topical treatment of psoriasis |
| 07/28/2004 | EP0696201B1 Supplemented tissue sealants, methods of their production and use |
| 07/28/2004 | CN1516705A Novel aryl fructose-1,6-bisphosphatase inhibitors |
| 07/28/2004 | CN1516701A (Pyrido/thieno)-[f]-oxazepin-5-one derivatives as AMPA receptor positive regulator |
| 07/28/2004 | CN1516700A Substituted 4H-chromenes and analogs as activators ofgasp ases and inducers of apoptosis and use thereof |
| 07/28/2004 | CN1516699A Polymorphic forms of 1-4-(5-cyanoindol-3-yl) butyl-4-(2-carbamoylbenzofuran-5-yl) piperazine hydrochloride |
| 07/28/2004 | CN1516698A Arylindenopyridines with PDE inhibiting activity |
| 07/28/2004 | CN1516697A Aromatic dicarboxylic acid derivatives |
| 07/28/2004 | CN1516695A Arylsulfonamides as antiviral agents |
| 07/28/2004 | CN1516693A Benzimidazoles that are useful in treating sexual dysfunction |
| 07/28/2004 | CN1516692A Novel compounds of family of 3-alkyl-(4,5-diphenyl-imidazol-1-yl) and their use as soothing agents |
| 07/28/2004 | CN1516691A Phenylpyridine carbonyl piperazine derivative |